
Recent Hyponatremia Correction Rate Data Is Becoming Harder to Ignore
Apr 20, 2026 - 10:08
Radio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & Podcasts
The double-blind, randomized phase III EMPEROR-Preserved trial showed a benefit of the sodium-glucose cotransporter-2 (SGLT2) inhibitor empagliflozin in patients with heart failure with preserved ejection fraction (HFpEF...
Heart Failure with Preserved Ejection Fraction (Diastolic CHF) and SGLT-2 Inhibitor Therapy is an episode from Hospital and Internal Medicine Podcast by Gil Porat, M.D., FACP, CPT. The double-blind, randomized phase III EMPEROR-Preserved tr...
This episode belongs to Hospital and Internal Medicine Podcast.
Use the player on this page to stream the episode online.
Published Jan 27, 2022, 11:32 long, audio available.